Diffusion-Weighted Imaging of White Matter Abnormalities in Patients with Phenylketonuria

References

1. ↵
   Folling A. Uber ausscheidung von phenylbrenztraubensaure in den harn als stoffwechselanomalie in verbindung mit Imbezillitat. Hoppe-Seylers Z Physiol Chem 1934;227:169-176

   Web of Science
2. ↵
   Menkes JM. Disorders of amino acid metabolism. In: Rowland LP, ed. Merritt's Textbook of Neurology. Media, PA: William and Wilkins; 1995:538–540
3. ↵
   Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679-688

   CrossRefPubMed
4. ↵
   Alvord EC, Stevenson LD, Vogel FS, Engle RL. Neuropathological findings in phenylpyruvic oligophrenia (phenylketonuria). J Neuropathol Exp Neurol 1950;9:298-310
5. ↵
   Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol 1966;25:2542-2568
6. ↵
   Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995;127:251-255

   CrossRefPubMedWeb of Science
7. ↵
   Jones SJ, Turano G, Kriss A, et al. Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ. J Neurol Neurosurg Psychiatry 1995;59:260-265

   Abstract/FREE Full Text
8. Pearsen KD, Gean-Marton AD, Levy HL, Davis KR. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 1990;177:437-440

   PubMedWeb of Science
9. Thompson AJ, Tillotson S, Smith I, et al. Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 1993;116:811-821

   Abstract/FREE Full Text
10. ↵
    Ullrich K, Moller H, Weglage J, et al. White matter abnormalities in phenylketonuria: results of magnetic resonance measurements. Acta Paediatr Suppl 1994;407:78-82

    PubMed
11. ↵
    Pietz J, Kreis R, Schmidt H, et al. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 1996;201:413-420

    PubMedWeb of Science
12. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninaemias. In: Scriver CR, et al. eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill; 1995:1015–1075
13. ↵
    Seashore MR, Wappner R, Cho S, de La Cruz F. Development of guidelines for treatment of children with phenylketonuria: report of a meeting at the National Institute of Child Health and Human Development held August 15, 1995, National Institutes of Health, Bethesda, Maryland. Pediatrics 1999;104:e67

    Abstract/FREE Full Text
14. Bauman ML, Kemper TL. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol (Berl) 1982;58:55-63

    CrossRefPubMed
15. ↵
    Hommes FA, Moss L. Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse. J Inherit Metab Dis 1992;15:243-251

    PubMed
16. Hasselbalch S, Knudsen GM, Toft PB, et al. Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria. Pediatr Res 1996;40:21-24

    PubMed
17. Bick U, Ullrich K, Stober U, et al. White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr 1993;152:1012-1020

    CrossRefPubMedWeb of Science
18. ↵
    Pierpaoli C, Righini A, Linfante I, et al. Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study. Radiology 1993;189:439-448

    PubMedWeb of Science
19. ↵
    Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999;20:1491-1499

    Abstract/FREE Full Text
20. ↵
    Morriss MC, Zimmerman RA, Bilaniuk LT, Hunter JV, Haselgrove JC. Changes in brain water diffusion during childhood. Neuroradiology 1999;41:929-934

    CrossRefPubMedWeb of Science